As part of this analysis, we detected mutations in tumor-suppressor genes not normally associated with lung cancer, novel LOF fusion events in critical tumor suppressors including PTEN and ATM, and passenger mutations in non-driver genes such as ATP7B, ERAP2, and TLR2 that may have functional and/or therapeutic significance. This evidence concerns the gene ATM and neoplasm.